Table 5.
Reasons for and against HPV vaccination
General Female Population
|
Healthcare Providers
|
Government Officials
|
||||
---|---|---|---|---|---|---|
Urban | Rural | Urban | Rural | Urban | Rural | |
Reasons for willingness to be vaccinated, multiple answers allowed (number, %) | ||||||
N=3,661 | N=5,358 | N=284 | N=338 | N=280 | N=372 | |
Self-benefit | 2,678 (73.1) | 4,165 (77.7) | 235 (82.7) | 273 (80.8) | 213 (76.1) | 283 (76.1) |
Benefit to other youth | 542 (14.8) | 912 (17.0) | 24 (8.5) | 67 (19.8) | 55 (19.6) | 100 (26.9) |
Fear of cervical cancer | 1,992 (54.4) | 3,503 (65.4) | 171 (60.2) | 228 (67.5) | 163 (58.2) | 247 (66.4) |
Fear of genital warts | 483 (13.2) | 944 (17.6) | 69 (24.3) | 111 (32.8) | 48 (17.1) | 93 (25.0) |
Fear of HPV infection | 1,383 (37.8) | 1,590 (29.7) | 142 (50.0) | 173 (51.2) | 120 (42.9) | 163 (43.8) |
Fear of having been infected with HPV | 272 (7.4) | 290 (5.4) | 31 (10.9) | 59 (17.5) | 33 (11.8) | 35 (9.4) |
| ||||||
Reasons against willingness to be vaccinated, multiple answers allowed (number, %) | ||||||
N=1,100 | N=1,561 | N=70 | N=68 | N=72 | N=39 | |
Belief in low self-risk | 302 (27.5) | 598 (38.3) | 23 (32.9) | 14 (20.6) | 17 (23.6) | 14 (35.9) |
Limited usage to date | 434 (39.5) | 353 (22.6) | 31 (44.3) | 32 (47.1) | 21 (29.2) | 14 (35.9) |
Belief that vaccination is risky | 563 (51.2) | 489 (31.3) | 49 (70.0) | 42 (61.8) | 52 (72.2) | 26 (66.7) |
Doubt of vaccine efficacy | 365 (33.2) | 326 (20.9) | 39 (55.7) | 37 (54.4) | 32 (44.4) | 17 (43.6) |
Doubt of source of vaccine | 164 (14.9) | 160 (10.2) | 12 (17.1) | 10 (14.7) | 14 (19.4) | 3 (7.7) |
Expense of vaccine | 226 (20.5) | 579 (37.1) | 9 (12.9) | 14 (20.6) | 9 (12.5) | 8 (20.5) |
Other | 87 (7.9) | 144 (9.2) | 2 ( 2.9) | 2 (2.9) | 0 (0.0) | 0 (0.0) |